# The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series

> **NCT03594565** · EARLY_PHASE1 · COMPLETED · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 13 (actual)

## Conditions studied

- T1DM
- Hypersensitivity

## Interventions

- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT03594565
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-06
- **Final completion:** 2018-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594565, "The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03594565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*